Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference
Business Wire
Nov 09, 2009
Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at
the 2009 Annual Credit Suisse Healthcare Conference will be webcast live
via the internet, on Friday, November 13, 2009 at 8:30 a.m. MST, 6:30
a.m. EST. To access the live webcast, please visit Biogen Idec’s
Investor Relations section (investor.biogenidec.com). An archived
version of the webcast will be available for 14 days following the
presentation.
About Biogen Idec
Biogen Idec creates new standards of care in therapeutic areas with high
unmet medical needs. Biogen Idec is a global leader in the discovery,
development, manufacturing, and commercialization of innovative
therapies. Patients in more than 90 countries benefit from Biogen Idec's
significant products that address diseases such as lymphoma, multiple
sclerosis, and rheumatoid arthritis. For product labeling, press
releases and additional information about the company, please visit www.biogenidec.com.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
